alisol-b-monoacetate and Hypersensitivity

alisol-b-monoacetate has been researched along with Hypersensitivity* in 1 studies

Other Studies

1 other study(ies) available for alisol-b-monoacetate and Hypersensitivity

ArticleYear
Alisol B 23-Acetate Inhibits IgE/Ag-Mediated Mast Cell Activation and Allergic Reaction.
    International journal of molecular sciences, 2018, Dec-18, Volume: 19, Issue:12

    Alisol B 23-acetate (AB23A), a natural triterpenoid, has been reported to exert hepatoprotective and antitumor activities. Aiming to investigate the anti-inflammatory activity, this study examined the effect of AB23A on mast cells and allergic reaction. AB23A inhibited the degranulation of mast cells stimulated by immunoglobulin E/antigen (IgE/Ag), and also decreased the synthesis of leukotriene C₄ (LTC₄), production of interlukin-6 (IL-6), and expression of cyclooxygenase-2 (COX-2) in a concentration-dependent manner with no significant cytotoxicity in bone marrow-derived mast cells (BMMCs). AB23A inhibited spleen tyrosine kinase (Syk) and the downstream signaling molecules including phospholipase Cγ (PLCγ), serine-threonine protein kinase/inhibitor of nuclear factor kappa-B kinase/nuclear factor kappa-B (Akt/IKK/NF-κB), and mitogen-activated protein kinases/cytosolic phospholipase A₂ (MAPK/cPLA₂). Furthermore, AB23A blocked mobilization of Ca

    Topics: Animals; Anti-Allergic Agents; Bone Marrow Cells; Cell Degranulation; Cholestenones; Humans; Hypersensitivity; Immunoglobulin E; Leukotriene C4; Mast Cells; Mice; Mitogen-Activated Protein Kinase Kinases; Phospholipase C gamma; Protein Serine-Threonine Kinases; Rats; Spleen; Syk Kinase

2018